Examination of bcl-2 and p53 expressions and apoptotic index by TUNEL method in psoriasis
dc.contributor.author | Gündüz K. | |
dc.contributor.author | Demireli P. | |
dc.contributor.author | Vatansever S. | |
dc.contributor.author | Inanir I. | |
dc.date.accessioned | 2024-07-22T08:23:08Z | |
dc.date.available | 2024-07-22T08:23:08Z | |
dc.date.issued | 2006 | |
dc.description.abstract | Background: Psoriasis is characterised by hyperproliferation and by aberrant differentiation. Blockage of the normal apoptotic process is one of the factors implicated in the pathogenesis. Objective: To determine the apoptotic features by using TUNEL method and also bcl-2 and p53 expressions in psoriatic epidermis. Materials and methods: Biopsies of 35 patients with psoriasis vulgaris and 14 normal skin were evaluated. Apoptotic cells were detected using the dUTP nick-end labelling assay; bc1-2 and p53 expressions were assessed by using immunohistochemical techniques. A semi-quantitative grading system (HSCORE) was used for comparison. Results: Bcl-2 was strongly expressed in basal keratinocytes of normal skin, while no expression was observed in 13 (37.2%) of the psoriatic samples and it was weakly expressed in the spinous cell layer of 22 (62.8%) samples. Moderate p53 expression was observed in the psoriasis group, while it was weak in the control. The percentage of TUNEL positive cells were significantly increased in the psoriasis group (65±2.30) when compared with the control (32.84±7.16). Conclusion: Apoptotic index besides bc1-2 and p53 expressions in psoriasis differ from normal epidermis. Down-regulation of bc1-2 is consistent with the dynamics of psoriasis but increased TUNEL positive cells and p53 expression has not been fully elucidated yet. © Blackwell Munksgaard 2006. | |
dc.identifier.DOI-ID | 10.1111/j.1600-0560.2006.00564.x | |
dc.identifier.issn | 16000560 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19374 | |
dc.language.iso | English | |
dc.subject | Apoptosis | |
dc.subject | Down-Regulation | |
dc.subject | Humans | |
dc.subject | Immunohistochemistry | |
dc.subject | In Situ Nick-End Labeling | |
dc.subject | Proto-Oncogene Proteins c-bcl-2 | |
dc.subject | Psoriasis | |
dc.subject | Tumor Suppressor Protein p53 | |
dc.subject | protein bcl 2 | |
dc.subject | protein p53 | |
dc.subject | apoptosis | |
dc.subject | article | |
dc.subject | cell differentiation | |
dc.subject | cell proliferation | |
dc.subject | clinical feature | |
dc.subject | controlled study | |
dc.subject | down regulation | |
dc.subject | epidermis | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | human tissue | |
dc.subject | immunohistochemistry | |
dc.subject | keratinocyte | |
dc.subject | nick end labeling | |
dc.subject | pathogenesis | |
dc.subject | protein expression | |
dc.subject | psoriasis | |
dc.subject | psoriasis vulgaris | |
dc.subject | quantitative analysis | |
dc.subject | skin biopsy | |
dc.title | Examination of bcl-2 and p53 expressions and apoptotic index by TUNEL method in psoriasis | |
dc.type | Article |